Fabien Gueugnon

691 total citations
23 papers, 498 citations indexed

About

Fabien Gueugnon is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fabien Gueugnon has authored 23 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fabien Gueugnon's work include Peptidase Inhibition and Analysis (6 papers), Histone Deacetylase Inhibitors Research (4 papers) and Click Chemistry and Applications (3 papers). Fabien Gueugnon is often cited by papers focused on Peptidase Inhibition and Analysis (6 papers), Histone Deacetylase Inhibitors Research (4 papers) and Click Chemistry and Applications (3 papers). Fabien Gueugnon collaborates with scholars based in France, Greece and Australia. Fabien Gueugnon's co-authors include Christophe Blanquart, Marc Grégoire, Yves Courty, Philìppe Bertrand, Daniel Pouliquen, Christine Sagan, A Petit, L. Cellerin, Arnaud Scherpereel and Valérie Héroguez and has published in prestigious journals such as Journal of Virology, Biochemical and Biophysical Research Communications and American Journal Of Pathology.

In The Last Decade

Fabien Gueugnon

23 papers receiving 494 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fabien Gueugnon France 14 250 114 107 101 60 23 498
Linda Jensen Denmark 14 416 1.7× 82 0.7× 98 0.9× 100 1.0× 20 0.3× 24 785
Ida Franiak‐Pietryga Poland 11 192 0.8× 103 0.9× 38 0.4× 135 1.3× 24 0.4× 25 424
Gary Li United States 13 355 1.4× 136 1.2× 89 0.8× 197 2.0× 51 0.8× 32 702
Ana Tavares Portugal 13 289 1.2× 143 1.3× 48 0.4× 103 1.0× 32 0.5× 19 502
Joseph Heintz United States 5 214 0.9× 98 0.9× 52 0.5× 119 1.2× 14 0.2× 8 453
Chang Song China 9 292 1.2× 299 2.6× 93 0.9× 210 2.1× 30 0.5× 25 665
Kanako Nanbu Japan 14 302 1.2× 93 0.8× 55 0.5× 111 1.1× 11 0.2× 21 681
Liliana Endo‐Munoz Australia 15 510 2.0× 90 0.8× 139 1.3× 233 2.3× 19 0.3× 21 764
Katia Bifulco Italy 16 336 1.3× 99 0.9× 47 0.4× 179 1.8× 36 0.6× 19 667
Michael Kneidinger Austria 16 214 0.9× 344 3.0× 104 1.0× 56 0.6× 45 0.8× 27 1.1k

Countries citing papers authored by Fabien Gueugnon

Since Specialization
Citations

This map shows the geographic impact of Fabien Gueugnon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabien Gueugnon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabien Gueugnon more than expected).

Fields of papers citing papers by Fabien Gueugnon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabien Gueugnon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabien Gueugnon. The network helps show where Fabien Gueugnon may publish in the future.

Co-authorship network of co-authors of Fabien Gueugnon

This figure shows the co-authorship network connecting the top 25 collaborators of Fabien Gueugnon. A scholar is included among the top collaborators of Fabien Gueugnon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabien Gueugnon. Fabien Gueugnon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Onodi, Fanny, Nadine Benhamouda, Fabien Gueugnon, et al.. (2018). High Therapeutic Efficacy of a New Survivin LSP-Cancer Vaccine Containing CD4+ and CD8+ T-Cell Epitopes. Frontiers in Oncology. 8. 517–517. 24 indexed citations
2.
Magnen, Mélia, Brigitta Elsässer, Petr Kašpárek, et al.. (2018). Kallikrein-related peptidase 5 and seasonal influenza viruses, limitations of the experimental models for activating proteases. Biological Chemistry. 399(9). 1053–1064. 9 indexed citations
3.
Magnen, Mélia, Fabien Gueugnon, Antoine Guillon, et al.. (2017). Kallikrein-Related Peptidase 5 Contributes to H3N2 Influenza Virus Infection in Human Lungs. Journal of Virology. 91(16). 19 indexed citations
4.
Gueugnon, Fabien, Virginie Thibault, Jennifer Kearley, et al.. (2016). Altered expression of the CCN genes in the lungs of mice in response to cigarette smoke exposure and viral and bacterial infections. Gene. 586(1). 176–183. 12 indexed citations
5.
Dalloneau, Emilie, Nadine Baroukh, Konstantinos Mavridis, et al.. (2016). Downregulation of the neonatal Fc receptor expression in non-small cell lung cancer tissue is associated with a poor prognosis. Oncotarget. 7(34). 54415–54429. 37 indexed citations
6.
Guillon, Antoine, Youenn Jouan, Fabien Gueugnon, et al.. (2015). Neutrophil proteases alter the interleukin-22-receptor-dependent lung antimicrobial defence. European Respiratory Journal. 46(3). 771–782. 35 indexed citations
7.
Mavridis, Konstantinos, Fabien Gueugnon, A Petit, et al.. (2015). The oncomiR miR-197 is a novel prognostic indicator for non-small cell lung cancer patients. British Journal of Cancer. 112(9). 1527–1535. 41 indexed citations
8.
Gueugnon, Fabien, Aurélia Barascu, Konstantinos Mavridis, et al.. (2015). Kallikrein-related peptidase 13: an independent indicator of favorable prognosis for patients with nonsmall cell lung cancer. Tumor Biology. 36(7). 4979–4986. 11 indexed citations
9.
Denis, Iza, Floraine Collette, Fabien Gueugnon, et al.. (2015). Histone deacetylase inhibitor-polymer conjugate nanoparticles for acid-responsive drug delivery. European Journal of Medicinal Chemistry. 95. 369–376. 23 indexed citations
10.
Gueugnon, Fabien, Pierre‐François Cartron, Cédric Charrier, et al.. (2014). New histone deacetylase inhibitors improve cisplatin antitumor properties against thoracic cancer cells. Oncotarget. 5(12). 4504–4515. 17 indexed citations
11.
Guillon, Antoine, Youenn Jouan, A Petit, & Fabien Gueugnon. (2013). Effets immunomodulateurs des macrolides au cours des pathologies respiratoires chroniques. Réanimation. 22(1). 24–33. 1 indexed citations
12.
Gueugnon, Fabien, Iza Denis, Daniel Pouliquen, et al.. (2013). Nanoparticles Produced by Ring-Opening Metathesis Polymerization Using Norbornenyl-poly(ethylene oxide) as a Ligand-Free Generic Platform for Highly Selective In Vivo Tumor Targeting. Biomacromolecules. 14(7). 2396–2402. 37 indexed citations
13.
Blanquart, Christophe, Fabien Gueugnon, Jean‐Michel Nguyen, et al.. (2012). CCL2, Galectin-3, and SMRP Combination Improves the Diagnosis of Mesothelioma in Pleural Effusions. Journal of Thoracic Oncology. 7(5). 883–889. 27 indexed citations
14.
Gueugnon, Fabien, Christophe Blanquart, Christine Sagan, et al.. (2011). Identification of Novel Markers for the Diagnosis of Malignant Pleural Mesothelioma. American Journal Of Pathology. 178(3). 1033–1042. 75 indexed citations
15.
Roulois, David, et al.. (2011). Downregulation of MUC1 expression and its recognition by CD8+ T cells on the surface of malignant pleural mesothelioma cells treated with HDACi. European Journal of Immunology. 42(3). 783–789. 12 indexed citations
16.
LeClercq, Sharon, Fabien Gueugnon, Bernard Boutin, et al.. (2011). A 5-aza-2′-deoxycytidine/valproate combination induces cytotoxic T-cell response against mesothelioma. European Respiratory Journal. 38(5). 1105–1116. 32 indexed citations
17.
Roulois, David, Virginie Vignard, Fabien Gueugnon, et al.. (2011). Recognition of pleural mesothelioma by mucin-1(950–958)/human leukocyte antigen A*0201-specific CD8+ T-cells. European Respiratory Journal. 38(5). 1117–1126. 13 indexed citations
18.
Gueugnon, Fabien, Catherine Gondcaille, Jérôme Bellenger, et al.. (2007). Dehydroepiandrosterone up-regulates the Adrenoleukodystrophy-related gene (ABCD2) independently of PPARα in rodents. Biochimie. 89(11). 1312–1321. 10 indexed citations
19.
Gueugnon, Fabien, Наталья Володина, Tatiana López, et al.. (2006). A novel cell model to study the function of the adrenoleukodystrophy-related protein. Biochemical and Biophysical Research Communications. 341(1). 150–157. 7 indexed citations
20.
Bugaut, Maurice, Stéphane Fourcade, Catherine Gondcaille, et al.. (2003). Pharmacological Induction of Redundant Genes for a Therapy of X-ALD. Advances in experimental medicine and biology. 544. 281–291. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda Jensen Breakdown of academic impact, for papers by Ida Franiak‐Pietryga Breakdown of academic impact, for papers by Gary Li Breakdown of academic impact, for papers by Ana Tavares Breakdown of academic impact, for papers by Joseph Heintz Breakdown of academic impact, for papers by Chang Song Breakdown of academic impact, for papers by Kanako Nanbu Breakdown of academic impact, for papers by Liliana Endo‐Munoz Breakdown of academic impact, for papers by Katia Bifulco Breakdown of academic impact, for papers by Michael Kneidinger
Rankless by CCL
2026